SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(van Guelpen Bethany)
 

Sökning: WFRF:(van Guelpen Bethany) > (2005-2009) > Plasma folate, vita...

Plasma folate, vitamin B12, and homocysteine and prostate cancer risk : a prospective study.

Hultdin, Johan (författare)
Umeå universitet,Klinisk kemi
Van Guelpen, Bethany (författare)
Umeå universitet,Patologi
Bergh, Anders (författare)
Umeå universitet,Patologi
visa fler...
Hallmans, Göran (författare)
Umeå universitet,Näringsforskning
Stattin, Pär (författare)
Umeå universitet,Urologi och andrologi
visa färre...
 (creator_code:org_t)
2004
2005
Engelska.
Ingår i: International Journal of Cancer. - : Wiley. - 0020-7136 .- 1097-0215. ; 113:5, s. 819-824
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The role of folate metabolism in cancer development is a topic of much current interest, with maintenance of adequate folate status tending to show a protective effect. Aberrant methylation, primarily hypermethylation of certain genes including tumor suppressors, has been implicated in prostate cancer development. Folate, vitamin B12 and homocysteine are essential for methyl group metabolism and thus also for DNA methylation. We related plasma levels of these factors to prostate cancer risk in a prospective study of 254 case subjects and 514 matched control subjects. Increasing plasma levels of folate and vitamin B12 were statistically significantly associated with increased prostate cancer risk, with an odds ratio of 1.60 (95% CI = 1.03-2.49; p(trend) = 0.02) for folate and 2.63 (95% CI = 1.61-4.29; p(trend) < 0.001) for vitamin B12 for highest vs. lowest quartile. Increasing plasma homocysteine levels were associated with a reduced risk of borderline significance (OR = 0.67; 95% CI = 0.43-1.04; p(trend) = 0.08). After adjustment for the other 2 plasma variables, body mass index and smoking, a statistically significant increased risk remained only for vitamin B12 (OR = 2.96; 95% CI = 1.58-5.55; p(trend) = 0.001). Adjusted OR for folate and homocysteine were 1.30 (95% CI = 0.74-2.24; p(trend) = 0.17) and 0.91 (95% CI = 0.51-1.58; p(trend) = 0.60), respectively. Our results suggest that factors contributing to folate status are not protective against prostate cancer. On the contrary, vitamin B12, associated with an up to 3-fold increase in risk, and possibly also folate, may even stimulate prostate cancer development. These findings are novel and should be explored further in future studies. (c) 2004 Wiley-Liss, Inc.

Nyckelord

Adult
Aged
Bone Neoplasms/blood/etiology/secondary
Case-Control Studies
Folic Acid/*blood
Homocysteine/*blood
Humans
Lymphatic Metastasis
Male
Middle Aged
Prospective Studies
Prostatic Neoplasms/blood/*epidemiology/*etiology
Risk Factors
Sweden/epidemiology
Vitamin B 12/*blood

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy